Skip to main content

Greenwich LifeSciences, Inc.

GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001799788

In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Greenwich LifeSciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of GLSI: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3635−1
Shares815.7K796.0K−19.7K (−2.4%)
Value$31.9M$19.4M−$12.5M (−39.2%)

New holders (6)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to GLSI in Q4 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC30,000$730.0K0.00%
Marshall Wace, LLP17,719$431.0K0.00%
HRT Financial LP15,971$388.0K0.00%
D. E. Shaw & Co., Inc.10,450$254.0K0.00%
SG Americas Securities, LLC4,395$107.0K0.00%
Advisor Group Holdings, Inc.50$1.00K0.00%

Sold out (7)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of GLSI in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Invesco Ltd.148,087$5.79M
Bank of Montreal28,229$1.13M
Tibra Equities Europe Ltd12,700$496.0K
SkyOak Wealth, LLC7,388$289.0K
Old Mission Capital LLC7,358$287.0K
State of Wisconsin Investment Board5,200$203.0K
Dorsey Wright & Associates1,118$44.0K